These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37470627)

  • 1. Expected usefulness of the third dose COVID-19 vaccine for cancerous patient.
    Mungmunpuntipantip R; Wiwanitkit V
    J Cancer Res Ther; 2023; 19(3):846. PubMed ID: 37470627
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 vaccine in cancerous patient receiving chemotherapy: Effect on safety margin for avoiding hyperviscosity.
    Joob B; Wiwanitkit V
    J Cancer Res Ther; 2023; 19(2):516. PubMed ID: 37313928
    [No Abstract]   [Full Text] [Related]  

  • 3. Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis.
    John BV; Ferreira RD; Doshi A; Kaplan DE; Taddei TH; Spector SA; Paulus E; Deng Y; Bastaich D; Dahman B
    J Hepatol; 2022 Nov; 77(5):1349-1358. PubMed ID: 36181987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myocarditis after a third dose of the BNT162b2 COVID-19 vaccine.
    Fosch X; Serra J; Torres PL; Preda L; González R; Mojer F
    Rev Esp Cardiol (Engl Ed); 2022 Jul; 75(7):614-616. PubMed ID: 35277352
    [No Abstract]   [Full Text] [Related]  

  • 5. In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine.
    Muthukumar A; Narasimhan M; Li QZ; Mahimainathan L; Hitto I; Fuda F; Batra K; Jiang X; Zhu C; Schoggins J; Cutrell JB; Croft CL; Khera A; Drazner MH; Grodin JL; Greenberg BM; Mammen PPA; Morrison SJ; de Lemos JA
    Circulation; 2021 Aug; 144(6):487-498. PubMed ID: 34133883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe myopericarditis following the third dose of an mRNA COVID-19 vaccine: utility of a multimodal treatment approach.
    Fritz RO; Betageri O; Chakrala T; Kim J; Al-Ani M; Omar A
    BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35768161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccination in a cancerous patient: A comment.
    Mungmungpuntipantip R; Wiwanitkit V
    J Cancer Res Ther; 2021; 17(6):1587. PubMed ID: 34916404
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of Vaccine Reactions After COVID-19 Vaccine Booster Doses Among Pregnant and Lactating Individuals.
    Kachikis A; Englund JA; Covelli I; Frank Y; Haghighi C; Singleton M; Drake AL; Eckert LO
    JAMA Netw Open; 2022 Sep; 5(9):e2230495. PubMed ID: 36074467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Talk to Patients About: Vaccine Testing.
    Price S
    Tex Med; 2020 Nov; 116(11):23. PubMed ID: 33641134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Efficacy and Safety of the Third Dose Inactivated COVID-19 Vaccine Among People Living With HIV.
    Tan Y; Zou S; Ming F; Zhang Z; Xing Z; Wu S; Guo W; Tang W; Liang K
    J Acquir Immune Defic Syndr; 2022 Jul; 90(3):e1-e3. PubMed ID: 35298450
    [No Abstract]   [Full Text] [Related]  

  • 11. 'Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine.
    Davido B; Mascitti H; Fortier-Beaulieu M; Jaffal K; de Truchis P
    J Travel Med; 2021 Jun; 28(4):. PubMed ID: 33620081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delirium triggered by COVID-19 vaccine in an elderly patient.
    Zavala-Jonguitud LF; Pérez-García CC
    Geriatr Gerontol Int; 2021 Jun; 21(6):540. PubMed ID: 33829614
    [No Abstract]   [Full Text] [Related]  

  • 13. Caution against injudicious vaccine allergy skin tests: Adverse reactions after intradermal COVID-19 vaccine testing.
    Chiang V; Mong PPT; Chan EKK; Au EYL; Li PH
    Contact Dermatitis; 2022 Mar; 86(3):213-214. PubMed ID: 34549437
    [No Abstract]   [Full Text] [Related]  

  • 14. Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine.
    García-Grimshaw M; Michel-Chávez A; Vera-Zertuche JM; Galnares-Olalde JA; Hernández-Vanegas LE; Figueroa-Cucurachi M; Paredes-Ceballos O; Reyes-Terán G; Carbajal-Sandoval G; Ceballos-Liceaga SE; Arauz A; Valdés-Ferrer SI
    Clin Immunol; 2021 Sep; 230():108818. PubMed ID: 34358692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myocarditis following a third dose of COVID-19 mRNA vaccination in adults.
    Simone A; Herald J; Chen A; Nayak R; Shen YA; Lee MS
    Int J Cardiol; 2022 Oct; 365():41-43. PubMed ID: 35870635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General determination of causation between Covid-19 vaccines and possible adverse events.
    Hampton LM; Aggarwal R; Evans SJW; Law B
    Vaccine; 2021 Mar; 39(10):1478-1480. PubMed ID: 33558107
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity and safety of different platforms of COVID-19 vaccines given as a third (booster) dose in healthy adults.
    Lin Z; Cheng M; Zhu F; Yang X; Zuo J; He S
    J Med Virol; 2022 Sep; 94(9):4047-4052. PubMed ID: 35521674
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
    Werbel WA; Boyarsky BJ; Ou MT; Massie AB; Tobian AAR; Garonzik-Wang JM; Segev DL
    Ann Intern Med; 2021 Sep; 174(9):1330-1332. PubMed ID: 34125572
    [No Abstract]   [Full Text] [Related]  

  • 19. No-Fault Compensation for Vaccine Injury - The Other Side of Equitable Access to Covid-19 Vaccines.
    Halabi S; Heinrich A; Omer SB
    N Engl J Med; 2020 Dec; 383(23):e125. PubMed ID: 33113309
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of COVID-19 vaccines: Types, thoughts, and application.
    Han X; Xu P; Ye Q
    J Clin Lab Anal; 2021 Sep; 35(9):e23937. PubMed ID: 34396586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.